The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Glucocorticoid Receptor Function In Vitro in Patients with Major Depression
Open accessAbstract
Clinical studies have demonstrated an impairment of glucocorticoid receptor (GR)-mediated negative feedback on the hypothalamic--pituitary--adrenal (HPA) axis in patients with major depression (GR resistance), and its resolution by antidepressant treatment. Interestingly, a number of studies have also demonstrated that GR function is reduced in vitro, in peripheral tissues of depressed patients, as shown by a decreased sensitivity to the effects of glucocorticoids on immune and metabolic functions. This paper reviews the in vitro studies that have examined GR function in patients with major depression, and the possible molecular mechanisms involved in GR resistance. Since several studies have demonstrated similar regulation of GR in the brain and in peripheral tissues in humans, and given limited access to brain GR in clinical populations, this review claims that in vitro studies are of particular relevance to understand the molecular mechanisms underlying GR abnormalities in patients with major depression and its regulation by antidepressant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Self-citationBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
Bamberger, C. M., Schulte, H. M., & Chrousos, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 912
McEwen, B. S., Biron, C. A., Brunson, K. W., Bulloch, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R. H., Kitson, R. P., Miller, A. H., Spencer, R. L., et al. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00012-4 · Cited by 837
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 741
(2000) · PubMed · Cited by 676
(1996) · PubMed · Cited by 547
Research works printed but not linked: 17
- Bourgeois S., 1993, Mol. Endocrinol., 7, 840
- Brooksbank B.W., 1973, Steroids Lipids Res, 4, 162
- Coupland N.J., 2003, J. Psychiatry Neurosci., 28, 364
- Czar M.J., 1995, Mol. Endocrinol., 9, 1549
- Denny W.B., 2000, Endocrinology, 141, 4107, 10.1210/endo.141.11.7785 · DOI · Paper page
- Herr A.S., 2003, Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro, Neuroendocrinology, 78, 12
- de Kloet E.R., 1998, Endocr. Rev., 19, 269
- Lopez J.F., 1998, Psychiatry, 43, 547
- Miller A.H., 1987, Psychopharmacol. Bull., 23, 502
- Miller A.H., 1999, Med. Biol., 461, 107
- Nemeroff C.B., 1996, Mol. Psychiatry, 1, 336
- Pariante C.M., 1999, Endocrinology, 140, 4359, 10.1210/endo.140.9.6986 · DOI · Paper page
- Rangarajan P.N., 1992, Mol. Endocrinol., 6, 1451
- Sallee F.R., 1995, Psychopharmacol. Bull., 31, 339
- Sanchez E.R., 1994, Mol. Endocrinol., 8, 408
- Webster M.J., 2002, Psychiatry, 7, 985
- Yang J., 1996, Mol. Endocrinol., 10, 3
Cited by
Sorted by citations
Salivary cortisol as a biomarker in stress research
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.026 · Cited by 1,925
The link between childhood trauma and depression: insights from HPA axis studies in humans
Heim, C., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.008 · Cited by 1,704
Russell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
Tyrka, A. R., Price, L. H., Marsit, C., Walters, O. C., & Carpenter, L. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030148 · Cited by 486
Neural control of chronic stress adaptation
Herman, J. P. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00061 · Cited by 384
Immune suppression and immune activation in depression
Blume, J., Douglas, S. D., & Evans, D. L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.008 · Cited by 338
Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability
de Punder, K., & Pruimboom, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00223 · Cited by 321
Bornstein, S. R., Schuppenies, A., Wong, M., & Licinio, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001873 · Cited by 278
Loftis, J. M., Huckans, M. S., & Morasco, B. J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.015 · Cited by 259
Origin of ultradian pulsatility in the hypothalamic–pituitary–adrenal axis
Walker, J. J., Terry, J. R., & Lightman, S. L. (2010) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2009.2148 · Cited by 239
“…been demonstrated by data showing a blunting of endogenous glucocorticoid inhibition following the administration of the synthetic glucocorticoid dexamethasone, or an inhibition of the ACTH response in the dexamethasone-CRH test (Nemeroff 1996; Holsboer 2000; Pariante & Miller 2001; Pariante 2004).”
BackgroundFrey, B. N., Andreazza, A. C., Houenou, J., Jamain, S., Goldstein, B. I., Frye, M. A., Leboyer, M., Berk, M., Malhi, G. S., Lopez-Jaramillo, C., et al. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413478217 · Cited by 234
Mendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S., & Brunello, N. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00005 · Cited by 229
A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks
Karin, O., Raz, M., Tendler, A., Bar, A., Korem Kohanim, Y., Milo, T., & Alon, U. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209510 · Cited by 200
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207
The glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192
Self-citationRisk Factors for Development of Depression and Psychosis
Pariante, C. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04978.x · Cited by 186
Self-citationGlucocorticoid Dysregulations and Their Clinical Correlates: From Receptors to Therapeutics
Marques, A. H., Silverman, M. N., & Sternberg, E. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04987.x · Cited by 158
Bertollo, A. G., Santos, C. F., Bagatini, M. D., & Ignácio, Z. M. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1541075 · Cited by 183
Different responses to dexamethasone and prednisolone in the same depressed patients
Juruena, M. F., Cleare, A. J., Papadopoulos, A. S., Poon, L., Lightman, S., & Pariante, C. M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0555-4 · Cited by 147
Self-citationRohleder, N., Wolf, J. M., & Wolf, O. T. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.003 · Cited by 150
Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139
Rohleder, N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.12.015 · Cited by 136
The HPA Axis as Target for Depression
Menke, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230811141557 · Cited by 131
“To reinstate homeostasis after stress response, negative feedback mechanisms are activated; cortisol binds to GR of the pituitary, the hippocampus, and the PVN, and inhibits the further release of CRH [43, 44].”
BackgroundThe putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 126
Tonelli, L. H., Holmes, A., & Postolache, T. T. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301488 · Cited by 126
Successful Antidepressant Therapy Restores the Disturbed Interplay Between TNF-α System and HPA Axis
Himmerich, H., Binder, E. B., Kunzel, H. E., Schuld, A., Lucae, S., Uhr, M., Pollmächer, T., Holsboer, F., & Ising, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.075 · Cited by 122
de Kloet, C. S., Vermetten, E., Bikker, A., Meulman, E., Geuze, E., Kavelaars, A., Westenberg, H. G. M., & Heijnen, C. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001934 · Cited by 98
Gold, S. M., Kruger, S., Ziegler, K. J., Krieger, T., Schulz, K., Otte, C., & Heesen, C. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230029 · Cited by 98
Kumar, G., Couper, A., O'Brien, T. J., Salzberg, M. R., Jones, N. C., Rees, S. M., & Morris, M. J. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.011 · Cited by 95
Martinez, E. J., Kolb, B., Bell, A., Savage, D. D., & Allan, A. M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.05.004 · Cited by 94
Aznar, S., & Knudsen, G. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100390 · Cited by 98
Role of Inflammation in Depression: Implications for Phenomenology, Pathophysiology and Treatment
Raison, C. L., & Miller, A. H. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343966 · Cited by 88
Alboni, S., Tascedda, F., Corsini, D., Benatti, C., Caggia, F., Capone, G., Barden, N., Blom, J. M. C., & Brunello, N. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.050 · Cited by 93
Glucocorticoid Receptor Polymorphisms in Major Depression
Claes, S. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05012.x · Cited by 84
Edwards, K. M., Bosch, J. A., Engeland, C. G., Cacioppo, J. T., & Marucha, P. T. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.03.011 · Cited by 76
Lu, S., Gao, W., Huang, M., Li, L., & Xu, Y. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.009 · Cited by 75
Carvalho, L. A., Juruena, M. F., Papadopoulos, A. S., Poon, L., Kerwin, R., Cleare, A. J., & Pariante, C. M. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.44 · Cited by 75
Self-citationThe neurobiology of suicide - A Review of post-mortem studies
Furczyk, K., Schutová, B., Michel, T. M., Thome, J., & Büttner, A. (2013) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-1-2 · Cited by 85
Hohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., Uhr, M., Holsboer, F., & Ising, M. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu087 · Cited by 74
Zebrafish models of major depressive disorders
Fonseka, T. M., Wen, X., Foster, J. A., & Kennedy, S. H. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23639 · Cited by 76
Glucocorticoid resistance syndrome: a diagnostic and therapeutic approach
van Rossum, E. F. C., & Lamberts, S. W. J. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.005 · Cited by 69
Hormones, Stress, and Cognition: The Effects of Glucocorticoids and Oxytocin on Memory
Wirth, M. M. (2014) · Adaptive Human Behavior and Physiology · doi:10.1007/s40750-014-0010-4 · Cited by 77
Nod-like receptors are critical for gut-brain axis signalling in mice
Pusceddu, M. M., Barboza, M., Keogh, C. E., Schneider, M., Stokes, P., Sladek, J. A., Kim, H. J. D., Torres‐Fuentes, C., Goldfild, L. R., Gillis, S. E., et al. (2019) · The Journal of Physiology · doi:10.1113/jp278640 · Cited by 69
Leistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Carter, R. N., Paterson, J. M., Tworowska, U., Stenvers, D. J., Mullins, J. J., Seckl, J. R., & Holmes, M. C. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01899.x · Cited by 68
In vitromodulation of the glucocorticoid receptor by antidepressants
Carvalho, L. A., & Pariante, C. M. (2008) · Stress · doi:10.1080/10253890701850759 · Cited by 69
Self-citationAre there meaningful biomarkers of treatment response for depression?
Breitenstein, B., Scheuer, S., & Holsboer, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.002 · Cited by 71
Altered functioning of the HPA axis in depressed postpartum women
de Rezende, M. G., Garcia-Leal, C., de Figueiredo, F. P., Cavalli, R. D. C., Schaufelberger, M. S., Barbieri, M. A., Bettiol, H., de Castro, M., & Del‐Ben, C. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.065 · Cited by 65
Liu, X., Zhou, Y., Li, Z., Cui, J., Li, Z., Gao, X., Sun, H., Zhang, L., Du, G., & Qin, X. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01412.x · Cited by 62
Pariante, C. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.067 · Cited by 58
Self-citationKatz, E. R., Stowe, Z. N., Newport, D. J., Kelley, M. E., Pace, T. W. W., Cubells, J. F., & Binder, E. B. (2011) · Psychological Medicine · doi:10.1017/s0033291711002121 · Cited by 58
Icariin attenuates social defeat-induced down-regulation of glucocorticoid receptor in mice
Wu, J., Du, J., Xu, C., Le, J., Xu, Y., Liu, B., & Dong, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.008 · Cited by 57
Carvalho, L. A., Garner, B., Dew, T. K., Fazakerley, H., & Pariante, C. M. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.006 · Cited by 58
Self-citationHeijnen, C. J. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.08.008 · Cited by 53
Mailliet, F., Qi, H., Rocher, C., Spedding, M., Svenningsson, P., & Jay, T. M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.030 · Cited by 60
Spiga, F., Harrison, L. R., Wood, S. A., Atkinson, H. C., MacSweeney, C. P., Thomson, F., Craighead, M., Grassie, M., & Lightman, S. L. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01605.x · Cited by 53
Özbey, G., Yucel, B., Taycan, S. E., Kan, D., Bodur, N. E., Arslan, T., Perçin, E. F., Yüksel, N., Güzey, C., & Uluoğlu, C. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.09.004 · Cited by 53
Neuroimmune endocrine effects of antidepressants
Carvalho, L. A. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16409 · Cited by 52
Kumsta, R., Moser, D., Streit, F., Koper, J. W., Meyer, J., & Wüst, S. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30837 · Cited by 55
Söderlund, J., & Lindskog, M. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy037 · Cited by 54
Hasselmann, H., Gamradt, S., Taenzer, A., Nowacki, J., Zain, R., Patas, K., Ramien, C., Paul, F., Wingenfeld, K., Piber, D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02693 · Cited by 50
Duffy, A. C., Lewitzka, U., Doucette, S., Andreazza, A. C., & Grof, P. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00323.x · Cited by 52
Gallagher, P., & Young, A. H. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a811 · Cited by 48
Yau, J. L. W., Noble, J., Thomas, S., Kerwin, R., Morgan, P. E., Lightman, S., Seckl, J. R., & Pariante, C. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301389 · Cited by 46
Self-citationMellon, S. H., Wolkowitz, O. M., Schonemann, M. D., Epel, E. S., Rosser, R., Burke, H. B., Mahan, L., Reus, V. I., Stamatiou, D., Liew, C. C., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.79 · Cited by 46
Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments
Porter, R., & Gallagher, P. (2006) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2006.00152.x · Cited by 47
Timonen, M., Salmenkaita, I., Jokelainen, J. J., Laakso, M., Härkönen, P. K., Koskela, P. U., Meyer‐Rochow, V. B., Peitso, A., & Keinanen-Kiukaanniemi, S. M. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318157ad2e · Cited by 45
Hu, F., Pace, T. W. W., & Miller, A. H. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.01.001 · Cited by 42
Aydin, A., Selvi, Y., Besiroglu, L., Boysan, M., Atli, A., Ozdemir, O., Kilic, S., & Balaharoglu, R. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.007 · Cited by 40
Mechanistic insights into corticosteroids in multiple sclerosis: War horse or chameleon?☆
Krieger, S. C., Sorrells, S. F., Nickerson, M., & Pace, T. W. W. (2014) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.12.021 · Cited by 40
Kumsta, R., Entringer, S., Koper, J. W., van Rossum, E. F. C., Hellhammer, D. H., & Wüst, S. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2008.04.007 · Cited by 40
Hageman, I., Nielsen, M., Wörtwein, G., Diemer, N. H., & Jørgensen, M. B. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.07.037 · Cited by 40
Changes in the Hypothalamic-Pituitary-Adrenal Axis and Leptin Levels during Antidepressant Treatment
Himmerich, H., Zimmermann, P., Ising, M., Kloiber, S. M., Lucae, S., Kunzel, H. E., Binder, E. B., Holsboer, F., & Uhr, M. (2007) · Neuropsychobiology · doi:10.1159/000103573 · Cited by 39
Bei, E., Salpeas, V., Pappa, D., Anagnostara, C., Alevizos, V., & Moutsatsou, P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.002 · Cited by 35
Wang, D., Lin, W., Pan, Y., KUANG, X.-Y., Qi, X., & Sun, H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.011 · Cited by 35
Spíndola, L., Pan, P. M., Moretti, P. N. S., Ota, V., Santoro, M. L., Cogo‐Moreira, H., Gadelha, A., Salum, G. A., Manfro, G. G., Mari, J. D. J., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.015 · Cited by 31
Lovallo, W. R., Enoch, M., Acheson, A., Cohoon, A. J., Sorocco, K. H., Hodgkinson, C. A., Vincent, A. S., & Goldman, D. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.347 · Cited by 31
Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients
Watanuki, T., Funato, H., Uchida, S., Matsubara, T., Kobayashi, A., Wakabayashi, Y., Otsuki, K., Nishida, A., & Watanabe, Y. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.003 · Cited by 34
IFN-γ Reduction by Tricyclic Antidepressants
Himmerich, H., Fulda, S., Sheldrick, A. J., Plümäkers, B., & Rink, L. (2010) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.40.4.e · Cited by 29
ŞAHİN, T. D., Göçmez, S. S., Duruksu, G., Yazır, Y., & Utkan, T. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01781-5 · Cited by 27
Lee, E., Cho, S., Kim, K., & Park, T. (2009) · Genomics · doi:10.1016/j.ygeno.2009.06.002 · Cited by 26
Lim, D. W., Han, D., & Lee, C.-H. (2022) · Molecules · doi:10.3390/molecules27113434 · Cited by 26
Ex vivo stimulation of whole blood as a means to determine glucocorticoid sensitivity
Marketon, J. I. W., Burnsides, Corry, J., -, A., Bálint, Cosmar, & Philips (2012) · Journal of Inflammation Research · doi:10.2147/jir.s33569 · Cited by 26
de Rezende, M. G., Rosa, C. E., Garcia-Leal, C., de Figueiredo, F. P., Cavalli, R. D. C., Bettiol, H., Salmón, C. E. G., Barbieri, M. A., de Castro, M., dos Santos, A. C., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.028 · Cited by 25
Goncharuk, V. D., Buijs, R. M., & Swaab, D. F. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21387 · Cited by 24
Andrade, S., Silveira, S. L., Gomez, R., Barros, H. M. T., & Ribeiro, M. F. M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.006 · Cited by 23
Spiga, F., Knight, D. M., Droste, S. K., Conway-Campbell, B. L., Kershaw, Y. M., MacSweeney, C. P., THOMSON, F. J., Craighead, M. W., Peeters, B. W. M. M., & Lightman, S. L. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109348175 · Cited by 24
Bernal-Sore, I., Navarro-Márquez, M., Osorio‐Fuentealba, C., Díaz‐Castro, F., del Campo, A., Donoso-Barraza, C., Porras, O. H., Lavandero, S., & Troncoso, R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.028 · Cited by 23
Hoomissen, J. D. V., Kunrath, J., Dentlinger, R. B., Lafrenz, A. J., Krause, M. A., & Azar, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.017 · Cited by 21
Niemegeers, P., Boer, P. D., Dumont, G., Eede, F. V. D., Fransén, E., Claes, S. J., Morrens, M., & Sabbe, B. (2016) · Neuropsychobiology · doi:10.1159/000466698 · Cited by 21
Phenytoin: an anti-bipolar anticonvulsant?
Bersudsky, Y. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006140 · Cited by 21
Akiyoshi, J., Tanaka, Y., Ishitobi, Y., Maruyama, Y., Kawano, A., Ando, T., Inoue, A., Imanaga, J., Okamoto, S., Kanehisa, M., et al. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s48722 · Cited by 21
Antiglucocorticoids, Neurogenesis and Depression
Fitzsimons, C. P., van Hooijdonk, L. W. A., Morrow, J. A., Peeters, B. W. M. M., Hamilton, N. M., Craighead, M. W., & Vreugdenhil, E. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787316001 · Cited by 19
Clinical Pharmacology and Therapeutics of Antidepressants
Ciraulo, D. A., Tsirulnik-Barts, L., Shader, R. I., & Greenblatt, D. J. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-792-5_2 · Cited by 20
Bekhbat, M., Ulukaya, G. B., Bhasin, M., Felger, J. C., & Miller, A. H. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100462 · Cited by 21
Saliva Estriol Levels in Women with and Without Prenatal Antidepressant Treatment
Suri, R., Hellemann, G., Cohen, L. S., Aquino, A., & Altshuler, L. L. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.015 · Cited by 19
Malviya, S. A., Kelly, S. D., Greenlee, M. M., Eaton, D. C., Duke, B. J., Bourke, C. H., & Neigh, G. N. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.03.018 · Cited by 17
Metadata
- Authors
- Pariante, C. M.
- Affiliations
- King's College London (GB)
- Corresponding author
- Pariante, Carmine M.
- ORCID
- Pariante, Carmine M.
- Venue
- Stress
- Publisher
- Informa UK Limited
- Published
- 2004-12
- Volume
- 7
- Issue
- 4
- Pages
- 209-219
- ISSN
- 1025-3890 (ISSN-L)
- 1607-8888
- OpenAlex
- W2056750568
- Cited by
- 147
- References
- 100
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 5 · 2018: 6 · 2017: 3 · 2016: 4 · 2015: 7 · 2014: 7 · 2013: 8 · 2012: 9
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Stress (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Rosetrees Trust
- Department of Science and Technology, Ministry of Science and Technology, India
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoid receptor, major depressive disorder, glucocorticoid resistance, hypothalamic-pituitary-adrenal axis, negative feedback, antidepressant treatment, peripheral tissues, immune function, metabolic function, molecular mechanisms
- MeSH terms
- Animals, Antidepressive Agents, Major Depressive Disorder, Humans, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review